Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06422104 · ClinicalTrials.gov registry record · NA
Neuromodulation Therapy for Task-Specific Dystonia
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT06422104 is a NA study that has completed, run by Duke University. The registered enrollment target is 12 participants.
The verdict
NCT06422104, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study aims to apply a non-invasive brain stimulation technology called repetitive Transcranial Magnetic Stimulation (rTMS) in patients with focal hand dystonia (FHD). The goal of the study is to identify which cortical target (premotor cortex (PMC) or primary somatosensory cortex (PSC)) will show benefit after active rTMS compared to sham rTMS. A secondary goal of the study is to understand if 10 Hz rTMS can show behavioral benefit compared to sham rTMS. The study will evaluate rTMS response using measures if writing on a sensor tablet, examiner and patient dystonia rating scales and brain imaging scan (functional MRI) to understand brain changes after rTMS. Safety measures include adherence to TMS guidelines and thorough medical screening to prevent seizures.
Interventions
- DEVICE Repetitive transcranial magnetic stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-08-23 |
| Est. Completion | 2023-01-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06422104
The ClinicalTrials.gov registry entry for NCT06422104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Repetitive transcranial magnetic stimulation is the first listed.
NCT06422104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06422104 about?
NCT06422104 is a clinical study titled "Neuromodulation Therapy for Task-Specific Dystonia". This study aims to apply a non-invasive brain stimulation technology called repetitive Transcranial Magnetic Stimulation (rTMS) in patients with focal hand dystonia (FHD). The goal of the study is to identify which cortical target (premotor cortex (PMC) or primary somatosensory cortex (PSC)) will sh...
What is the current status of trial NCT06422104?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-08-23. Estimated completion is 2023-01-13.
What interventions are being tested in trial NCT06422104?
The interventions under investigation include: Repetitive transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT06422104?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.